Literature DB >> 3530504

Separation of immunomodulatory effects of mannan from Candida albicans into stimulatory and suppressive components.

J E Domer, P W Stashak, K Elkins, B Prescott, G Caldes, P J Baker.   

Abstract

Mannan extracted from Candida albicans was studied for its immunomodulatory activity on in vivo antibody responses to type III pneumococcal polysaccharide (SSS-III), a helper-T-cell-independent antigen, and to sheep erythrocytes (SRBC), a helper-T-cell-dependent antigen. In some studies, the antibody response to SSS-III was converted to a helper-T-cell-dependent response by attaching it to a carrier (horse erythrocytes, HRBC); this complex then was used to immunize mice primed with a subimmunogenic dose of HRBC. Mannan enhanced the antibody response to both SSS-III and SRBC when administered at the same time or 1 or 2 days after immunogen. However, when both mannan and SSS-III were coated onto HRBC for immunization, either enhancement or suppression was noted; the effect depended upon the amount of mannan used. Larger amounts stimulated, whereas smaller amounts suppressed, the antibody response to SSS-III. The enhancing and suppressive components of mannan could be separated by molecular size or charge by chromatography on Sepharose 4B or on DEAE-Sephadex A-50 columns, indicating that mannan extracts contain individual components having opposing immunomodulatory properties. These components can be separated on the basis of molecular size and charge.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3530504     DOI: 10.1016/0008-8749(86)90153-x

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  10 in total

1.  Mannan as an antigen in cell-mediated immunity (CMI) assays and as a modulator of mannan-specific CMI.

Authors:  J E Domer; R E Garner; R N Befidi-Mengue
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

2.  Candida albicans induces the release of inflammatory mediators from human peripheral blood monocytes.

Authors:  M Castro; J A Bjoraker; M S Rohrbach; A H Limper
Journal:  Inflammation       Date:  1996-02       Impact factor: 4.092

3.  Enhancement of non-Candida antibody responses by Candida albicans cell wall glycoprotein.

Authors:  J E Domer; K L Elkins; D L Ennist; P W Stashak; R E Garner; P J Baker
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

Review 4.  Immunological aspects of fungal pathogenesis.

Authors:  G S Deepe; W E Bullock
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-08       Impact factor: 3.267

Review 5.  Candida mannan: chemistry, suppression of cell-mediated immunity, and possible mechanisms of action.

Authors:  R D Nelson; N Shibata; R P Podzorski; M J Herron
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

6.  The Carbohydrate Lectin Receptor Dectin-1 Mediates the Immune Response to Exserohilum rostratum.

Authors:  Jennifer L Reedy; Paige E Negoro; Marianela Feliu; Allison K Lord; Nida S Khan; Dan P Lukason; Nathan P Wiederhold; Jenny M Tam; Michael K Mansour; Thomas F Patterson; Jatin M Vyas
Journal:  Infect Immun       Date:  2017-02-23       Impact factor: 3.441

7.  Structural identification of an epitope of antigenic factor 5 in mannans of Candida albicans NIH B-792 (serotype B) and J-1012 (serotype A) as beta-1,2-linked oligomannosyl residues.

Authors:  N Shibata; M Arai; E Haga; T Kikuchi; M Najima; T Satoh; H Kobayashi; S Suzuki
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

8.  Proliferative and cytotoxic responses to mannoproteins of Candida albicans by peripheral blood lymphocytes of HIV-infected subjects.

Authors:  I Quinti; C Palma; E C Guerra; M J Gomez; I Mezzaroma; F Aiuti; A Cassone
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

Review 9.  Production and function of cytokines in natural and acquired immunity to Candida albicans infection.

Authors:  R B Ashman; J M Papadimitriou
Journal:  Microbiol Rev       Date:  1995-12

Review 10.  Carbohydrate Conjugates in Vaccine Developments.

Authors:  Shuyao Lang; Xuefei Huang
Journal:  Front Chem       Date:  2020-04-15       Impact factor: 5.221

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.